Panel discussion - PSCK9 inhibition: a new horizon in LDL-C management.
Topic:
Lipids
Speaker:
Professor C. Cannon (Boston, US)
Professor A. Catapano (Milan, IT)
Doctor J. Robinson (Iowa, US)
Sponsored by Sanofi and Regeneron
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Professor Christopher Paul Cannon
Brigham and Women's Hospital, Boston (United States of America)
38
presentations
0
follower
Professor Alberico Catapano
IRCCS - MultiMedica, Milan (Italy)
46
presentations
3
followers
Doctor Jennifer Robinson
University of Iowa, Iowa (United States of America)
12
presentations
0
follower
2 more presentations in this session
Introduction - PSCK9 inhibition: a new horizon in LDL-C management.
Speaker: Professor A. Catapano (Milan, IT) Doctor J. Robinson (Iowa, US) Professor C. Cannon (Boston, US)
Identifying appropriate patients to treat: clinical cases and evidence discussion.
Speaker: Doctor J. Robinson (Iowa, US)
Access the full session
PSCK9 inhibition: a new horizon in LDL-C management
Speakers:
Professor C. Cannon, Professor A. Catapano, Doctor J. Robinson, Professor A. Catapano, Doctor J. Robinson...
About the event
ESC 365 is supported by
